Robert Spiera

16.8k total citations · 2 hit papers
169 papers, 6.8k citations indexed

About

Robert Spiera is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Robert Spiera has authored 169 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Pulmonary and Respiratory Medicine, 65 papers in Pathology and Forensic Medicine and 62 papers in Rheumatology. Recurrent topics in Robert Spiera's work include Vasculitis and related conditions (97 papers), Systemic Sclerosis and Related Diseases (59 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (44 papers). Robert Spiera is often cited by papers focused on Vasculitis and related conditions (97 papers), Systemic Sclerosis and Related Diseases (59 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (44 papers). Robert Spiera collaborates with scholars based in United States, Netherlands and United Kingdom. Robert Spiera's co-authors include Peter A. Merkel, Ulrich Specks, Gary S. Hoffman, E. William St. Clair, John H. Stone, Jessica Gordon, John C. Davis, John H. Stone, Sebastian Unizony and Philip Seo and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Robert Spiera

162 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Tocilizumab in Giant-Cell Arteritis

2017 815 citations John H. Stone, Katie Tuckwell et al. New England Journal of Medicine profile →
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

2015 265 citations Michael L. Whitfield, Robert Spiera et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Spiera United States	41	4.7k	2.9k	1.7k	1.4k	1.3k	169	6.8k
Bernhard Hellmich Germany	38	4.7k 1.0×	2.9k 1.0×	1.1k 0.6×	1.2k 0.9×	603 0.5×	160	6.2k
Bhaskar Dasgupta United Kingdom	40	6.5k 1.4×	4.9k 1.7×	2.3k 1.3×	972 0.7×	545 0.4×	166	8.2k
Renato Alberto Sinico Italy	39	5.6k 1.2×	3.8k 1.3×	1.4k 0.8×	1.5k 1.0×	654 0.5×	140	7.9k
Caroline O.S. Savage United Kingdom	41	4.1k 0.9×	1.9k 0.7×	1.3k 0.8×	1.9k 1.3×	476 0.4×	86	6.3k
María C. Cid Spain	55	7.3k 1.6×	5.3k 1.9×	2.2k 1.3×	2.2k 1.6×	730 0.6×	204	11.4k
Carlos García‐Porrúa Spain	45	3.8k 0.8×	4.2k 1.5×	1.0k 0.6×	1.6k 1.1×	416 0.3×	154	6.9k
Luigi Boiardi Italy	46	4.7k 1.0×	4.3k 1.5×	1.7k 1.0×	1.1k 0.8×	339 0.3×	197	6.9k
E. Christiaan Hagen Netherlands	29	6.1k 1.3×	2.7k 0.9×	1.8k 1.0×	1.0k 0.7×	433 0.3×	52	7.1k
Pieter van Paassen Netherlands	37	3.1k 0.7×	1.5k 0.5×	1.1k 0.7×	1.2k 0.9×	400 0.3×	113	4.8k
Kerstin Westman Sweden	33	7.0k 1.5×	3.2k 1.1×	2.6k 1.5×	1.1k 0.8×	456 0.4×	71	7.8k

Countries citing papers authored by Robert Spiera

Since Specialization

Citations

This map shows the geographic impact of Robert Spiera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Spiera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Spiera more than expected).

Fields of papers citing papers by Robert Spiera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Spiera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Spiera. The network helps show where Robert Spiera may publish in the future.

Co-authorship network of co-authors of Robert Spiera

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Spiera. A scholar is included among the top collaborators of Robert Spiera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Spiera. Robert Spiera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spiera, Robert, Valérie Devauchelle‐Pensec, Claire Owen, et al.. (2025). Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial. Arthritis & Rheumatology. 77(8). 1041–1051. 2 indexed citations

Lakin, Kimberly S., John Spivack, Jessica Gordon, et al.. (2025). Skin Biopsies Enhance Prediction of Clinical Trajectory in Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology. 78(2). 418–427.

Specks, Ulrich, Robert Spiera, Lynn A. Fussner, et al.. (2025). Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. ACR Open Rheumatology. 7(1). e11795–e11795. 4 indexed citations

Spiera, Robert, et al.. (2024). Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series. The Journal of Rheumatology. 51(4). 390–395. 1 indexed citations

Denton, Christopher P., Robert Spiera, David J. Jörg, et al.. (2023). AB0904 BELIMUMAB FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS: A PHASE 2/3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Annals of the Rheumatic Diseases. 82. 1668–1668. 1 indexed citations

Khanna, Dinesh, Paul H. Caldron, Richard W. Martin, et al.. (2022). Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial. Arthritis & Rheumatology. 74(8). 1399–1408. 20 indexed citations

Chaudhary, Vidyanath, Marie Dominique Ah Kioon, Sung‐Min Hwang, et al.. (2022). Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses. The Journal of Experimental Medicine. 219(11). 42 indexed citations

Moura, Marta Casal, Darlene R. Nelson, Lynn A. Fussner, et al.. (2022). Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3. Arthritis & Rheumatology. 75(5). 748–759. 1 indexed citations

Jannat‐Khah, Deanna, et al.. (2022). B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab. The Journal of Rheumatology. 50(3). jrheum.220475–jrheum.220475. 5 indexed citations

10.

Nguyen, Joseph, Linda Kwakkenbos, Marie‐Eve Carrier, et al.. (2022). Mental Health Care Use and Associated Factors in Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study. ACR Open Rheumatology. 4(8). 647–657.

11.

Gordon, Jessica, Yin Wu, Linda Kwakkenbos, et al.. (2022). Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study. UCL Discovery (University College London). 9 indexed citations

12.

Spiera, Robert, Laura K. Hummers, Leland W.K. Chung, et al.. (2020). Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis. Arthritis & Rheumatology. 72(8). 1350–1360. 72 indexed citations

13.

Owczarczyk, Kasia, Matthew D. Cascino, Cécile Holweg, et al.. (2020). Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis. JCI Insight. 5(18). 9 indexed citations

14.

Kwakkenbos, Linda, Marie‐Eve Carrier, Jessica Gordon, et al.. (2019). Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study. The Journal of Rheumatology. 46(12). 1605–1613. 13 indexed citations

15.

Berti, Alvise, Roscoe L. Warner, Kent J. Johnson, et al.. (2018). Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Arthritis & Rheumatology. 70(7). 1114–1121. 48 indexed citations

16.

Stone, John H., Katie Tuckwell, Sophie Dimonaco, et al.. (2017). Trial of Tocilizumab in Giant-Cell Arteritis. New England Journal of Medicine. 377(4). 317–328. 815 indexed citations breakdown →

17.

Lafyatis, Robert, Julio Mantero, Jessica Gordon, et al.. (2017). Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82. Journal of Investigative Dermatology. 137(12). 2473–2483. 38 indexed citations

18.

Johnson, Michael E., Andrew V. Grassetti, Jaclyn Taroni, et al.. (2016). Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis. Arthritis Research & Therapy. 18(1). 27–27. 16 indexed citations

19.

Miloslavsky, Eli M., Ulrich Specks, Peter A. Margolis, et al.. (2013). Efficacy Of Glucocorticoids To Treat Limited Flares In ANCA-Associated Vasculitis. Data Archiving and Networked Services (DANS). 1 indexed citations

20.

Stone, John H., Gary S. Hoffman, Peter A. Merkel, et al.. (2001). A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score. Arthritis & Rheumatism. 44(4). 912–920. 352 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact